Skip to main content
Peer-to-Peer Webinar

National Webinar with Endocrinologist, Dr. Barbara Hirsch Removing Known Barriers to Mealtime Insulin Dosing with CeQur Simplicity (with Patient Case Study) Wednesday, April 26, 2023 5:30 PM PT /  7:30 PM CT / 8:30 PM ET: Register Here Thursday, May 4, 2023 3:30 PM PT / 5:30 PM CT / 6:30 PM ET: Register Here

CeQur Raises $115 Million Series C5

CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the close of an oversubscribed $115 million equity financing. The company will use the […]

CeQur Appoints Bradley Paddock Chief Executive Officer

CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, notably leading sales up to $600 million during his eight-year tenure at Kyphon, Inc. Paddock also managed successful commercial operations for multiple industry-leading companies, including Stryker, Bausch + Lomb, Inc., and […]

CeQur Acquires Assets from Calibra Medical, Inc.

CeQur® today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™. The Calibra system enables people with diabetes to discreetly and conveniently deliver rapid-acting […]